Defamation trouble for Rakhi Sawant and a lawyer from Sameer Wankhede.
Read Full ArticleThe Delhi High Court has ruled in favour of Pharmacyclics LLC and Johnson & Johnson Pvt Ltd (Johnson & Johnson) in a patent infringement suit moved by them for violation of their rights in targeted cancer treatment drug, Ibrutinib, marketed as Imbruvica. Find out all about the case here.
The Meghalaya High Court, in M Kharkongor vs. State of Meghalaya March 30, 2022, addressed allegations of drug trafficking using Army vehicles.
![Pharmacyclics, Johnson & Johnson win patent infringement suit for anti-cancer drug [Read Judgment]](/secure/uploads/2024/01/lj_5765_WhatsApp_Image_2024-01-03_at_5.45.56_PM.jpeg)
